Evidence map›Paper›PMID 33257764›Full record

ArticleNature communications2020

Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.

Matthew H Bailey, William U Meyerson, Lewis Jonathan Dursi, Liang-Bo Wang, Guanlan Dong, Wen-Wei Liang, Amila Weerasinghe, Shantao Li, Yize Li, Sean Kelso and 11 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 20 institutions in 33 countries.

Matthew H BaileyThe McDonnell Genome Institute at Washington University, St. Louis, MO, 63108, USA.ORCID http://orcid.org/0000-0003-4526-9727
William U MeyersonYale School of Medicine, Yale University, New Haven, CT, 06520, USA.
Lewis Jonathan DursiComputational Biology Program, Ontario Institute for Cancer Research, Toronto, ON, M5G 0A3, Canada.ORCID http://orcid.org/0000-0002-4697-798X
Liang-Bo WangThe McDonnell Genome Institute at Washington University, St. Louis, MO, 63108, USA.ORCID http://orcid.org/0000-0001-6977-9348
Guanlan DongDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63108, USA.ORCID http://orcid.org/0000-0002-4747-6036
Wen-Wei LiangThe McDonnell Genome Institute at Washington University, St. Louis, MO, 63108, USA.
Amila WeerasingheThe McDonnell Genome Institute at Washington University, St. Louis, MO, 63108, USA.ORCID http://orcid.org/0000-0003-3568-5823
Shantao LiProgram in Computational Biology and Bioinformatics, Yale University, New Haven, CT, 06520, USA.ORCID http://orcid.org/0000-0002-5440-2780
Yize LiThe McDonnell Genome Institute at Washington University, St. Louis, MO, 63108, USA.
Sean KelsoDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63108, USA.
MC3 Working Group
PCAWG novel somatic mutation calling methods working group
Gordon SaksenaBroad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.ORCID http://orcid.org/0000-0001-6630-7935
Kyle EllrottBiomedical Engineering, Oregon Health and Science University, Portland, OR, 97239, USA.ORCID http://orcid.org/0000-0002-6573-5900
Michael C WendlThe McDonnell Genome Institute at Washington University, St. Louis, MO, 63108, USA.
David A WheelerHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, 77030, USA.ORCID http://orcid.org/0000-0002-9056-6299
Gad GetzBroad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.ORCID http://orcid.org/0000-0002-0936-0753
Jared T SimpsonComputational Biology Program, Ontario Institute for Cancer Research, Toronto, ON, M5G 0A3, Canada.
Mark B GersteinProgram in Computational Biology and Bioinformatics, Yale University, New Haven, CT, 06520, USA. mark.gerstein@yale.edu.ORCID http://orcid.org/0000-0002-9746-3719
Li DingThe McDonnell Genome Institute at Washington University, St. Louis, MO, 63108, USA. lding@wustl.edu.
PCAWG Consortium
Ontario Institute for Cancer Research · CABroad Institute · USWellcome Sanger Institute · GBGerman Cancer Research Center · DEThe University of Texas MD Anderson Cancer Center · USUniversity of North Carolina at Chapel Hill · USMemorial Sloan Kettering Cancer Center · USJames S. McDonnell Foundation · USCanada's Michael Smith Genome Sciences Centre · CAThe University of Sydney · AUThe University of Melbourne · AUUniversity of Cambridge · GBWashington University in St. Louis · USEuropean Bioinformatics Institute · GBNational Institutes of Health · USThe University of Queensland · AUUniversity of Toronto · CAUniversity of Verona · ITYale University · USBaylor College of Medicine · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel · 2001 to 2026
$36.3M
Cancer Research UK 20952Cancer Research UK 25813NCI NIH HHS P30 CA016672NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

Correction to this paper has been published: https://doi.org/10.1038/s41467-020-20128-w.

Identifiers

PMID33257764
PMCPMC7705717
OpenAlexW3108878321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.